期刊文献+

药用辅料的不良反应及其安全性管理 被引量:45

Adverse reactions of pharmaceutical excipients and their safety management
原文传递
导出
摘要 药用辅料系药物制剂中除活性成分以外所有物料的统称,其功能除赋形外,还能保持或增加活性成分的稳定性和生物利用度。据估计,现有40余类上千种药用辅料,如溶剂、吸附剂、防腐剂、着色剂、矫味剂、增稠剂、抗氧剂等;另外,近年还出现一些新型辅料。辅料相对于活性成分而言,是一种惰性物质。然而,现有资料证明,许多辅料可引起不良反应,如丙二醇致溶血、苯甲醇致喘息综合征等。药用辅料的安全性涉及其毒性、质量和不正确使用。临床医师应了解与辅料相关的不良反应,药品管理部门也应加强辅料的安全性管理以利于维护患者安全。 Pharmaceutical excipients refer to any substances other than the active principal in the pharmaceutical preparation.Their functions are to protect,support or enhance the stability and bioavaila bility of the active ingredient besides formulating a dosage form.It is reckoned that 40 kinds and more of pharmaceutical excipients including over one thousan d different materials are now used in the manufacturing of pharmaceutical products,such as solvents,absorbents,preservations,colouring agents,flavouring agents,thickening agents,antioxidants,and so on.In addition,new classes of exc ipients have been available in recent years.Pharmaceutical excipients are consi dered to be inert in contrast to active drug.However,adverse reactions to a wide range of excipients are now documented,such as hemolysis to propylene glycol,gasping syndrome to benzyl alcohol,etc.The safety of pharmaceutical excipients involves their toxicity,quality,and improper use.The clinicians should be aware of the adverse reactions associated with pharmaceutical excipients,and drug regulatory authority should strengthen the management of the safety of pharma ceutical excipients in order to safeguard the patient safety.
作者 吕秋军 曹萍
出处 《药物不良反应杂志》 2010年第6期410-414,共5页 Adverse Drug Reactions Journal
关键词 药用辅料 不良反应 安全性 pharmaceutical excipients adverse reactions safety
  • 相关文献

参考文献18

  • 1张龙涛,梁毅.我国药用辅料标准中存在的问题及改进对策[J].上海医药,2007,28(12):537-538. 被引量:12
  • 2吴晋,余美乐.我国药用辅料管理现状分析及发展趋势[J].海峡药学,2007,19(9):131-133. 被引量:19
  • 3Kiss T,Fenyvesi F,Bácskay I,et al.Evaluation of the cytotoxicity of beta-cyelodextrin derivatives:evidence for the role of cholesterol extraction[J].Eur J Pharm Sci,2010,40(4):376-380.
  • 4Biondi O,Motta S,Mosesso P.Low molecular weight polyethylene glycol induces chromosome aberrations in Chinese hamster cells cultured in vitro[J].Mutagenesis,2002,17(3):261-264.
  • 5Anderson CW,Ng KJ,Andresen B,et al.Benzyl alcohol poisoning in a premature newborn infant[J].Am J Obstet Gynecol,1984,148(3):344-346.
  • 6郑策,梅丹,王兰,李大魁,汤光.关注制剂中辅料的不良反应[J].中国药学杂志,2005,40(9):644-649. 被引量:143
  • 7罗翀.疫苗中硫柳汞的争议探讨[J].中国现代药物应用,2009,3(14):190-191. 被引量:9
  • 8American Academy of Pediatrics Committee on Drugs."Inactive" ingredients in pharmaceutical products:update (subject review)[J].Pediatrics,1997,99 (2):268-278.
  • 9氨基酸输液部颁标准起草工作会议纪要.药典通讯,1997,.
  • 10Virchow C,Szczeklik A,Bianco S,et al.Intolerance to tartrazine in aspirin-induced asthma; results of a multicenter study.Respiration[J].1988,53(1):20-23.

二级参考文献104

  • 1张阳德,李浩.纳米载体肝靶向纳米药物研究进展[J].中国医学工程,2003,11(6):75-77. 被引量:10
  • 2盛洁,山登布卡,谢蜀生,魏树礼.单克隆抗体BDI-I导向的阿霉素白蛋白毫微球对人膀胱癌细胞的特异杀伤活性[J].药学学报,1995,30(9):706-710. 被引量:12
  • 3.GB 15193.5-94.骨髓微核试验[S].,..
  • 4BALA I, HARIHARAN S, KUMAR M N. PLGA nanoparticles in drug delivery: the state of the art[J]. Crit Rev Ther Drug Carrier Sys,2004,21(5):387-422.
  • 5SINGH M, BRIONES M, OTT G, etal. Cationiem icropartieles: A potent delivery system for DNA vaecines[J]. Proc Natl Acad Sci U S A,2000,97(2):811-816.
  • 6BIRNBAUM D T, KOSMALA J D, HENTHORN D B. Controlled release of estradiol from PLGA microparticles: the effect of organic phase solvent on encapsulation and realease[J]. J Control Release,2000,65(3) :375-387.
  • 7KOHN D B, SADELAIN M, GLORIO S O J C. Occurrence of leukaemia following gene therapy of X-linked SCID[J]. Nat Rev Cancer, 2003,7(3) :477-488.
  • 8FERBER D. Gene therapy: Safer and v rus-free?[J]. Science, 2001,294(5547) :1638-1642.
  • 9LEE K Y, KWON I C, KIM Y H, et al. Preparation of ehitosan self-aggregates as a gene delivery system[J]. J Control Release, 1998,51(2-3):213- 220.
  • 10PATRA C R, BHATTACHARYA R, WANG E, etal. Targeted delivery of gemeitabine to pancreatic adenocareinoma using cetuximab as a targeting agent [J]. Cancer Res, 2008, 68 (6); 1970-1978.

共引文献216

同被引文献429

引证文献45

二级引证文献296

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部